This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Effects of Sativex on ECG
and you are
between 18 and 45
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study was to evaluate effects of Sativex on electrocardiogram (ECG) traces when administered at its therapeutic dose of 8 sprays per day and at multiples of the therapeutic dose (24 or 36 sprays per day), and to evaluate its safety and tolerability.

Provided treatments

  • Drug: Placebo spray and oral moxifloxacin placebo
  • Drug: Sativex spray and oral moxifloxacin placebo
  • Drug: Sativex spray and oral moxifloxacin placebo
  • Drug: Placebo spray and moxifloxacin

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01322139. The sponsor of the trial is GW Pharmaceuticals Ltd. and it is looking for 258 volunteers for the current phase.
Official trial title:
A Multiple-Dose, Randomized, Double-Blind, Placebo- and Active-Controlled, Four-Arm, Parallel Group Thorough QT/QTc Study to Evaluate the Electrophysiologic Effects of Sativex.